IGFBP2 and metabolic dysfunction-associated steatotic liver disease: Some IGFBPs have been related to fibrosis in different tissues [28,29,30,31]; here, in MCD-induced NAFLD, we observed an increase in the expression of IGFBP-2 and IGFBP-7 in the liver (Figure 4c,e).